Pricing Log in Create free account
Monday 9 November 2026 Export CUVL’s income statement to Excel — free account

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR

CUVL

Healthcare Biotechnology

5.10 0.08 +1.59%
Market cap
$257.5M
P/E
—
Fwd P/E
—
Dividend yield
0.56%
F-score
n/a
ROIC
—
Net debt / EBITDA
—
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Columns are period end dates · fundamentals updated 2 Nov 2026